ASTRAZENECA PLC
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 24, 2026 | CICC | initiate | — → Outperform | — | 59% |
| Feb 13, 2025 | UBS | upgrade | Neutral → Buy | $0 | 54% |
| Nov 20, 2024 | UBS | upgrade | Sell → Neutral | $0 | 54% |
| Sep 11, 2024 | Erste Group | upgrade | Hold → Buy | $0 | 50% |
| Aug 12, 2024 | TD Cowen | maintain | Buy → Buy | $95 | 54% |
| May 30, 2024 | Argus Research | maintain | Buy → Buy | $85 | 53% |
| May 30, 2024 | Goldman Sachs | initiate | — → Buy | $97 | 54% |
| Apr 26, 2024 | BMO Capital | maintain | Outperform → Outperform | $82 | 53% |
| Apr 16, 2024 | Deutsche Bank | upgrade | Sell → Hold | $0 | 57% |
| Feb 12, 2024 | BMO Capital | maintain | Outperform → Outperform | $80 | 53% |
| Feb 8, 2024 | Deutsche Bank | downgrade | Buy → Hold | $0 | 57% |
| Jan 23, 2024 | Morgan Stanley | initiate | — → Overweight | $85 | 54% |
| Jan 3, 2024 | Jefferies | downgrade | Buy → Hold | $0 | 52% |
| Sep 25, 2023 | Jefferies | upgrade | Hold → Buy | $80 | 52% |
| Sep 8, 2023 | Erste Group | downgrade | Buy → Hold | $0 | 50% |
| Aug 1, 2023 | BMO Capital | maintain | Outperform → Outperform | $83 | 53% |
| May 26, 2023 | Argus Research | maintain | Buy → Buy | $80 | 53% |
| Apr 13, 2023 | Argus Research | maintain | — → Buy | $85 | 53% |
| Jan 5, 2023 | BMO Capital | initiate | — → Outperform | $82 | 53% |
| Nov 14, 2022 | SVB Leerink | maintain | — → Outperform | $79 | — |
| Nov 11, 2022 | SVB Leerink | maintain | — → Outperform | $78 | — |
| Aug 29, 2022 | Argus Research | upgrade | Hold → Buy | $75 | 53% |
| May 4, 2022 | SVB Leerink | maintain | — → Outperform | $75 | — |
| Feb 24, 2022 | SVB Leerink | maintain | — → Outperform | $70 | — |
| Feb 11, 2022 | DZ Bank | upgrade | Sell → Hold | $0 | 40% |
| Dec 7, 2021 | Jefferies | downgrade | Buy → Hold | $0 | 52% |
| Sep 27, 2021 | SVB Leerink | maintain | — → Outperform | $73 | — |
| Sep 20, 2021 | SVB Leerink | maintain | — → Outperform | $71 | — |
| Aug 4, 2021 | SVB Leerink | maintain | — → Outperform | $69 | — |
| Jul 16, 2021 | SVB Leerink | maintain | — → Outperform | $63 | — |
| Jun 4, 2021 | SVB Leerink | maintain | — → Outperform | $64 | — |
| Apr 12, 2021 | Argus Research | downgrade | Buy → Hold | $0 | 53% |
| Mar 16, 2021 | Jefferies | upgrade | Hold → Buy | $0 | 52% |
| Mar 2, 2021 | SVB Leerink | maintain | — → Outperform | $63 | — |
| Feb 25, 2021 | UBS | upgrade | Neutral → Buy | $0 | 54% |
| Jan 15, 2021 | Deutsche Bank | initiate | — → Buy | $0 | 57% |
| Dec 7, 2020 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $0 | 54% |
| May 29, 2020 | SVB Leerink | maintain | — → Outperform | $65 | — |
| May 6, 2020 | Argus Research | maintain | — → Buy | $60 | 53% |
| Dec 2, 2019 | Cowen & Co. | maintain | — → Outperform | $55 | — |
| Nov 22, 2019 | SVB Leerink | initiate | — → Outperform | $0 | — |
| Apr 2, 2019 | UBS | downgrade | Neutral → Sell | $0 | 54% |
| Apr 1, 2019 | Cowen & Co. | upgrade | Market Perform → Outperform | $48 | — |
| Dec 14, 2018 | SunTrust Robinson Humphrey | initiate | — → Buy | $48 | — |
| Nov 19, 2018 | Investec | downgrade | Buy → Hold | $0 | — |
| Aug 16, 2018 | Jefferies | downgrade | Buy → Hold | $0 | 52% |
| Mar 19, 2018 | Jefferies | upgrade | Hold → Buy | $0 | 52% |
| Feb 6, 2018 | Leerink Swann | maintain | Market Perform → Market Perform | $38 | — |
| Dec 29, 2017 | JP Morgan | upgrade | Neutral → Overweight | $0 | 54% |
| Oct 23, 2017 | Leerink Swann | maintain | — → Market Perform | $34 | — |
No cross-platform signals in the last 90 days